🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy by Vinay Mathew Thomas, Nicolas Sayegh, MD et al buff.ly/3Dcj6PQ #UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010 by Jose Antonio Karam et al buff.ly/3ZOIp34 #UroSoMe #MedTwitter #EUO #RCC

International Variations in Adherence to Quality Metrics for Locoregional Prostate Cancer by Adam B. Weiner, MD et al buff.ly/3DbN6ex #UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT Study by Daimantas Milonas et al buff.ly/3BqRqWM #UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

Robot-assisted Partial Nephrectomy for Hilar and Nonhilar Renal Masses: Comparison of Perioperative, Oncological, and Functional Results in a Multicentre Prospective Cohort (NEPRAH Study, UroCCR 175) by Julien Sarkis et al buff.ly/3ZMBt6K #UroSoMe #MedTwitter #EUO

Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group by francesco soria et al buff.ly/3Bg84Zj #UroSoMe #MedTwitter #EUO

Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results Registry by Alex Zhu et al buff.ly/49BrhRL #UroSoMe #MedTwitter #EUO

PTEN Loss Is Associated with Adverse Outcomes in the Setting of Salvage Radiation Therapy by Emerson Lee, Lia DePaula Oliveira, Oluwademilade Dairo et al buff.ly/3BD8FEi #UroSoMe #MedTwitter #EUO

Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate Cancer by Derya Tilki, MD et al buff.ly/49BnlRd #UroSoMe #MedTwitter #EUO #PCa #ProstateCaner

Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney by Vivian Tan MD, Rohann Correa et al buff.ly/3ZLN99L #UroSoMe #MedTwitter #EUO #RenalCellCarcinoma

Contemporary Diagnosis of Very Low-risk Prostate Cancer in a Multihospital Health Care System by Richard Bennett et al buff.ly/49wNQHp #UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort by Marco Finati, Matthew Davis et al buff.ly/4gbwN03 #UroSoMe #MedTwitter #ProstateCancer #PCa

Congratulations to Dr. Zhenjie Wu, the recepient of our first Reviewer Recognition Award! Your commitment to maintaining the high standards of our journal helps keep us at the forefront of oncological urological research. Thank you!

Make sure to check out the NEW EAU Guidelines on our website! europeanurology.com/inpress

What's going on today? European Urology meets The Lancet: The future of urological care Join us to while experts will discuss an exciting collaboration on 3 groundbreaking papers that will shape the future of urological research and care! Chairs: Alberto Briganti and Vania

Congratulations to Dr. Michael Baboudjian, the recipient of Reviewer Recognition Award! Your commitment to maintaining the high standards of our journal helps keep us at the forefront of oncological urological research. Thank you! #UroSoMe #Urology #ReviewerRecognitionAward

Follow us on Telegram for the latest updates from the European Urology family of journals — European Urology, European Urology Focus, European Urology Oncology, and European Urology Open Science. Be the first to read new articles, editorials, special issues, and key

Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized The latest IBCG consensus in European Urology offers global expert recommendations on when, how, and for whom bladder-sparing strategies are appropriate

The EAU is at the AUA — and we’ve brought the fun! 🎉 Come find us at Booth 418: 🧦 Buy a pair of our famous Willy Socks 🎁 Grab some awesome swag 📍 Pick up your membership pin 📚 Get your hands on the latest EAU Guidelines We can’t wait to meet you — stop by, say hi, and

Don't Miss Out – Free Access Until the End of April! To celebrate the 50th anniversary of European Urology, all current and past issues from the European Urology Family of Journals are free to access until April 30! Enjoy groundbreaking research, expert reviews, and key insights